# Helios Dr. Horst Schmidt Kliniken Wiesbaden

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/helios-dr-horst-schmidt-kliniken-wiesbaden/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 64 |
| Citations | 151,558 |
| City | Wiesbaden |
| Country | DE |
| Description | Helios Dr. Horst Schmidt Kliniken Wiesbaden is a research organisation in Wiesbaden, DE. OpenAlex records 7,749 works and 151,558 citations for it. 1,439 researchers list it as their most recent affiliation. |
| Homepage | https://www.helios-gesundheit.de/kliniken/wiesbaden-hsk/ |
| OpenAlex ID | https://openalex.org/I2800878633 |
| Researchers | 1,439 |
| ROR ID | https://ror.org/03kxagd85 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q1253768 |
| Works | 7,749 |

## University papers

Showing 12 of 13.

- [Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors](https://scholariq.org/papers/phase-3-trial-of-sup-177-sup-lu-dotatate-for-midgut-neuroendocrine-tumors/)
- [The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours](https://scholariq.org/papers/the-joint-iaea-eanm-and-snmmi-practical-guidance-on-peptide-receptor/)
- [Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors](https://scholariq.org/papers/long-term-tolerability-of-prrt-in-807-patients-with-neuroendocrine-tumours-the/)
- [Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With <sup>177</sup>Lu-Dotatate in the Phase III NETTER-1 Trial](https://scholariq.org/papers/health-related-quality-of-life-in-patients-with-progressive-midgut/)
- [EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)](https://scholariq.org/papers/eanm-procedure-guidelines-for-radionuclide-therapy-with-177lu-labelled-psma/)
- [Treatment of recurrent ovarian cancer](https://scholariq.org/papers/treatment-of-recurrent-ovarian-cancer/)
- [Identification of six new susceptibility loci for invasive epithelial ovarian cancer](https://scholariq.org/papers/identification-of-six-new-susceptibility-loci-for-invasive-epithelial-ovarian/)
- [Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase](https://scholariq.org/papers/operability-and-chemotherapy-responsiveness-in-advanced-low-grade-serous-ovarian/)
- [ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer](https://scholariq.org/papers/abca-transporter-gene-expression-and-poor-outcome-in-epithelial-ovarian-cancer/)
- [Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases](https://scholariq.org/papers/triple-negative-and-her2-overexpressing-breast-cancers-exhibit-an-elevated-risk/)
- [Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer](https://scholariq.org/papers/progression-free-survival-and-safety-at-3-5-years-of-follow-up-results-from-the/)
- [Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial](https://scholariq.org/papers/health-related-quality-of-life-in-patients-with-newly-diagnosed-advanced-ovarian/)

## University researchers

- [Florian Heitz](https://scholariq.org/researchers/florian-heitz/)

## University top topics

Showing 8 of 10.

- [Digital Innovation in Industries](https://scholariq.org/topics/digital-innovation-in-industries/)
- [Sociology and Education Studies](https://scholariq.org/topics/sociology-and-education-studies/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Health and Medical Studies](https://scholariq.org/topics/health-and-medical-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Flexible and Reconfigurable Manufacturing Systems](https://scholariq.org/topics/flexible-and-reconfigurable-manufacturing-systems/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [German Literature and Culture Studies](https://scholariq.org/topics/german-literature-and-culture-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.